Given that a similar proinflammatory response is also observed in COVID-19, the severe forms of COVID-19 are most likely attributable to the hyperactivation of NF-κβ that regulates the synthesis and release of proinflammatory cytokines, such as TNF-α and IL-6, in severe COVID-19 patients. This evidence concerns the gene NFKB1 and COVID-19.